<DOC>
	<DOCNO>NCT01220752</DOCNO>
	<brief_summary>The IMRT-HIT-SNT trial prospective , mono-centric , phase II trial evaluate toxicity efficacy combine treatment intensity-modulated radiation therapy ( IMRT ) carbon ion ( C12 ) boost . Primary endpoint mucositis ≥ CTC°3 , secondary endpoint local control , disease-free survival , overall survival , toxicity . Planned accrual trial include 36 patient histologically proven ( ≥R1-resected inoperable ) sinonasal malignancy .</brief_summary>
	<brief_title>Treatment Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy ( IMRT ) Carbon Ion Boost ( C12 )</brief_title>
	<detailed_description>Local control sinonasal malignancy dose dependent . However , dose escalation acceptable toxicity technically demand even modern radiotherapy technique . Raster-scanned carbon ion therapy highly conformal dose distribution may allow high dos comparable reduced side-effects . Methods/ design : The IMRT-HIT-SNT trial prospective , mono-centric , phase II trial evaluate toxicity combine treatment intensity-modulated radiation therapy ( IMRT ) carbon ion ( C12 ) boost 36 patient histologically proven ( ≥R1-resected inoperable ) adeno-/ squamous cell carcinoma nasal cavity paransal sinus . Patients receive 24 GyE carbon ion ( 8 fraction ) IMRT ( 2.0 Gy/ fraction ) . Study objective : Incidence mucositis ≥ CTC°3 assess primary endpoint trial , local control , disease-free survival , overall survival , toxicity ( incl . mucositis CTC °I-II late toxicity 2 year post RT ) secondary endpoint .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Paranasal Sinus Neoplasms</mesh_term>
	<criteria>Histologically confirm surgically remove adenocarcinoma squamous cell carcinoma nasal cavity paranasal sinuses Inoperable tumour refusal undergo surgical resection Macroscopic microscopic residual tumour ( R2/ R1 ) ≥T3/T4 write informed consent pt age 18 80 year effective contraception pt childbearing age ( &lt; 12 month post begin menopause ) Prior radio chemotherapy tumour head neck Other previous malignancy within past 5 year except prior , adequately treat basal cell carcinoma skin preinvasive carcinoma cervix Significant neurological psychiatric condition include dementia seizure serious medical condition prohibit patient 's participation trial judgement investigator Legal incapacity limit legal capacity Positive serum/ urine betaHCG/ pregnancy Drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>IMRT</keyword>
	<keyword>carbon ion therapy</keyword>
	<keyword>paranasal sinus</keyword>
	<keyword>nasal cavity</keyword>
	<keyword>adenocarcinoma</keyword>
	<keyword>squamous cell carcinoma</keyword>
</DOC>